Literature DB >> 11889358

The structure and invariance of a model of social functioning in schizophrenia.

John S Brekke1, Jeffrey D Long, Diane D Kay.   

Abstract

The authors proposed and tested a model of social functioning in schizophrenia. The model consisted of five indicators: social competence, quality of relations, satisfaction, symmetry of relationships, and the number of close friends. The model combines proximal and distal, quality and quantity, and self-report and observer ratings of social functioning. It was designed to have ecological validity in that it reflects real-world social functioning, and the data are all gathered in reference to naturally occurring social contexts. Two independent community samples of individuals diagnosed with schizophrenia or schizoaffective disorder (N = 172; N = 166) were used to test the structure of the measurement model and its invariance across samples. Additional measures of social functioning, prognosis, and intrapsychic deficits were used to further assess the validity of the proposed social functioning construct. A single-factor model had acceptable fit with the data from sample 1. The single-factor model was found to be invariant across the two independent samples. Correlations with other measures in both samples provided additional evidence for the construct validity of the proposed measurement model of social functioning. Implications for research and practice are discussed.

Entities:  

Mesh:

Year:  2002        PMID: 11889358     DOI: 10.1097/00005053-200202000-00001

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  8 in total

1.  Social value of supported employment for psychosocial program participants.

Authors:  Paul J Barreira; Miriam Cohen Tepper; Paul B Gold; Dana Holley; Cathaleene Macias
Journal:  Psychiatr Q       Date:  2011-03

2.  A dual change model of life satisfaction and functioning for individuals with schizophrenia.

Authors:  Melissa Edmondson; Rohini Pahwa; Karen Kyeunghae Lee; Maanse Hoe; John S Brekke
Journal:  Schizophr Res       Date:  2012-05-14       Impact factor: 4.939

Review 3.  Real-world cognitive--and metacognitive--dysfunction in schizophrenia: a new approach for measuring (and remediating) more "right stuff".

Authors:  Danny Koren; Larry J Seidman; Morris Goldsmith; Phillip D Harvey
Journal:  Schizophr Bull       Date:  2006-01-05       Impact factor: 9.306

4.  The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008.

Authors:  David Cella; William Riley; Arthur Stone; Nan Rothrock; Bryce Reeve; Susan Yount; Dagmar Amtmann; Rita Bode; Daniel Buysse; Seung Choi; Karon Cook; Robert Devellis; Darren DeWalt; James F Fries; Richard Gershon; Elizabeth A Hahn; Jin-Shei Lai; Paul Pilkonis; Dennis Revicki; Matthias Rose; Kevin Weinfurt; Ron Hays
Journal:  J Clin Epidemiol       Date:  2010-08-04       Impact factor: 6.437

5.  Prosocial family processes and the quality of life of persons with schizophrenia.

Authors:  Jan S Greenberg; Kraig J Knudsen; Kelly A Aschbrenner
Journal:  Psychiatr Serv       Date:  2006-12       Impact factor: 3.084

6.  Measuring participation: the Patient-Reported Outcomes Measurement Information System experience.

Authors:  Rita K Bode; Elizabeth A Hahn; Robert DeVellis; David Cella
Journal:  Arch Phys Med Rehabil       Date:  2010-09       Impact factor: 3.966

7.  Measuring social health in the patient-reported outcomes measurement information system (PROMIS): item bank development and testing.

Authors:  Elizabeth A Hahn; Robert F Devellis; Rita K Bode; Sofia F Garcia; Liana D Castel; Susan V Eisen; Hayden B Bosworth; Allen W Heinemann; Nan Rothrock; David Cella
Journal:  Qual Life Res       Date:  2010-04-25       Impact factor: 4.147

8.  Determining dimensions of iranians' individual social health: a qualitative approach.

Authors:  K Abachizadeh; S Omidnia; N Memaryan; Aa Nasehi; M Rasouli; B Tayefi; A Nikfarjam
Journal:  Iran J Public Health       Date:  2013-01-01       Impact factor: 1.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.